# A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

> **NCT01942369** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 402 (actual)

## Conditions studied

- Deep Infiltrating Endometriosis (DIE)

## Interventions

- **DRUG:** Triptorelin Acetate 3.75mg intramuscular injection

## Key facts

- **NCT ID:** NCT01942369
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-16
- **Primary completion:** 2018-07-13
- **Final completion:** 2018-07-13
- **Target enrollment:** 402 (ACTUAL)
- **Last updated:** 2018-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01942369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01942369, "A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01942369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*